Abstract
For a body of work to eventually be designated as a “Landmark” article may require years of analysis, further investigative support, and frequent citations in future articles. In this issue of Current Neurovascular Research, we are introducing the publication of pioneering original articles in combination with “state-of the-art” review articles that may someday be considered significant building blocks for future lines of investigation. In several respects, the articles focus upon the ability of ischemic cell injury to not only lead to acute or chronic nervous system impairment in a variety of disorders, but also to actively generate reparative processes that may even result from activities considered as simple as physical exercise.
Current Neurovascular Research
Title: From the Editors Perspective: Activity, Anoxia, Angiogenesis, and Alzheimers Disease
Volume: 1 Issue: 5
Author(s): Kenneth Maiese
Affiliation:
Abstract: For a body of work to eventually be designated as a “Landmark” article may require years of analysis, further investigative support, and frequent citations in future articles. In this issue of Current Neurovascular Research, we are introducing the publication of pioneering original articles in combination with “state-of the-art” review articles that may someday be considered significant building blocks for future lines of investigation. In several respects, the articles focus upon the ability of ischemic cell injury to not only lead to acute or chronic nervous system impairment in a variety of disorders, but also to actively generate reparative processes that may even result from activities considered as simple as physical exercise.
Export Options
About this article
Cite this article as:
Maiese Kenneth, From the Editors Perspective: Activity, Anoxia, Angiogenesis, and Alzheimers Disease, Current Neurovascular Research 2004; 1 (5) . https://dx.doi.org/10.2174/1567202043361947
DOI https://dx.doi.org/10.2174/1567202043361947 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mediterranean Diet, Brain and Muscle: Olive Polyphenols and Resveratrol Protection in Neurodegenerative and Neuromuscular Disorders
Current Medicinal Chemistry Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules
Current Pharmaceutical Design Cyclic Nucleotides Signaling and Phosphodiesterase Inhibition: Defying Alzheimer’s Disease
Current Drug Targets Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition
Medicinal Chemistry The Problem of Amino Acid Complementarity and Antisense Peptides
Current Protein & Peptide Science Alzheimer’s Disease and Retinal Degeneration: A Glimpse at Essential Trace Metals in Ocular Fluids and Tissues
Current Alzheimer Research Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics
Current Pharmaceutical Design Denouement of Chemicals on Amyotrophic Lateral Sclerosis: Is Green Chemistry the Answer
Medicinal Chemistry Topical Delivery of Drugs for the Effective Treatment of Fungal Infections of Skin
Current Pharmaceutical Design Non-Demented Individuals with Alzheimer’s Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies
Current Pharmaceutical Design Association of Prolyl Oligopeptidase with Conventional Neurotransmitters in the Brain
CNS & Neurological Disorders - Drug Targets A Glimpse of Matrix Metalloproteinases in Diabetic Nephropathy
Current Medicinal Chemistry Ignored Avenues in Alpha-Synuclein Associated Proteopathy
CNS & Neurological Disorders - Drug Targets The Function of Tyrosine Hydroxylase in the Normal and Parkinsonian Brain
CNS & Neurological Disorders - Drug Targets Personalized Drug Discovery: HCA Approach Optimized for Rare Diseases at Tel Aviv University
Combinatorial Chemistry & High Throughput Screening A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Therapeutic Targets for the Management of Peripheral Nerve Injury- Induced Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Ethnobotanical Treatment Strategies Against Alzheimers Disease
Current Alzheimer Research Receptor to Glutamate NMDA-Type: The Functional Diversity of the NR1 Isoforms and Pharmacological Properties
Current Pharmaceutical Design Pituitary Adenylate Cyclase Activating Polypeptide: A Potential Neuroprotective Peptide
Current Pharmaceutical Design